Literature DB >> 26432672

Lipophilic Statins and Aldosterone Secretion: A Bridge Too Far?

Charlotte Andersson1, Ramachandran S Vasan2.   

Abstract

Entities:  

Keywords:  Editorials; aldosterone; mineralocorticoids; statin

Mesh：

Substances：

Year:  2015        PMID： 26432672      PMCID： PMC4974093          DOI： 10.1161/CIRCULATIONAHA.115.019130

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  28 in total

1.  Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.

Authors:  Alessia Buglioni; Valentina Cannone; Alessandro Cataliotti; S Jeson Sangaralingham; Denise M Heublein; Christopher G Scott; Kent R Bailey; Richard J Rodeheffer; Paolo Dessì-Fulgheri; Riccardo Sarzani; John C Burnett
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction – ALPS-AMI study.

Authors:  Atsushi Izawa; Yuichiro Kashima; Takashi Miura; Soichiro Ebisawa; Hiroshi Kitabayashi; Hiroaki Yamamoto; Shunpei Sakurai; Mitsuru Kagoshima; Takeshi Tomita; Yusuke Miyashita; Jun Koyama; Uichi Ikeda
Journal:  Circ J       Date:  2014-11-12       Impact factor: 2.993

Review 3.  Statins in community acquired pneumonia: Evidence from experimental and clinical studies.

Authors:  James D Chalmers; Philip M Short; Pallavi Mandal; Ahsan R Akram; Adam T Hill
Journal:  Respir Med       Date:  2010-05-05       Impact factor: 3.415

4.  Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.

Authors:  H Ide; S Fujiya; Y Aanuma; Y Agishi
Journal:  Clin Ther       Date:  1990 Sep-Oct       Impact factor: 3.393

5.  More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines.

Authors:  John P A Ioannidis
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

6.  Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study.

Authors:  A I Kanaki; P A Sarafidis; P I Georgianos; P C Stafylas; K Kanavos; I M Tziolas; A N Lasaridis
Journal:  J Hum Hypertens       Date:  2011-09-01       Impact factor: 3.012

7.  Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.

Authors:  Fabrice Ivanes; Sophie Susen; Frédéric Mouquet; Pascal Pigny; François Cuilleret; Karine Sautière; Jean-Philippe Collet; Farzin Beygui; Bernadette Hennache; Pierre Vladimir Ennezat; Françis Juthier; Florence Richard; Jean Dallongeville; Marieke A Hillaert; Pieter A Doevendans; Brigitte Jude; Michel Bertrand; Gilles Montalescot; Eric Van Belle
Journal:  Eur Heart J       Date:  2011-06-30       Impact factor: 29.983

8.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

9.  Simvastatin reduces sympathetic activity in men with hypertension and hypercholesterolemia.

Authors:  Jacek Lewandowski; Maciej Siński; Joanna Bidiuk; Piotr Abramczyk; Anna Dobosiewicz; Agnieszka Ciarka; Zbigniew Gaciong
Journal:  Hypertens Res       Date:  2010-07-29       Impact factor: 3.872

10.  Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.

Authors:  Koichi Node; Masashi Fujita; Masafumi Kitakaze; Masatsugu Hori; James K Liao
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690
View more
  1 in total

1.  Response to Letter Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".

Authors:  Rene Baudrand; Luminita Pojoga; Anand Vaidya; Amanda Garza; Paul Vöhringer; Xavier Jeunemaitre; Paul Hopkins; Tham Yao; Jonathan Williams; Gail Adler; Gordon Williams
Journal:  Circulation       Date:  2016-04-19       Impact factor: 29.690
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.